share_log

康华生物(300841.SZ)收到HilleVax支付首付款1500万美元

Kanghua Biotech (300841.SZ) received a down payment of US$15 million from HillEvax

Zhitong Finance ·  Mar 27 07:56

Kanghua Biotech (300841.SZ) announced the signing of a recombinant hexavalent norovirus vaccine with HillEvax...

Zhitong Finance App News, Kanghua Biotech (300841.SZ) announced that regarding the progress of signing a license agreement with HillEvax for the recombinant six-valent norovirus vaccine, the company received a down payment of 15 million US dollars from HillEvax on March 26, 2024, of which the net amount was 13.5 million US dollars and HillEvax withheld income tax of 1.5 million US dollars.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment